DascenaLogo

Dascena develops algorithms as predictive
biomarkers for complex conditions

Our suite of AlgoDiagnosticsTM  for acute decompensation, sepsis, and
acute kidney injury autonomously processes electronic health record
data
 to enable early intervention and improve care outcomes.

High Accuracy

High sensitivity (>90%) and specificity (>85%) means our AlgoDiagnostics can help deliver care to more patients while avoiding false positives and alert fatigue.

Broadly Applicable

Our AlgoDiagnostics are used in a variety of clinical settings from academic medical centers to critical access hospitals. And it works with all major EHRs.

Power of Prediction

Our AlgoDiagnostics can predict onset of complex conditions several hours or days in advance when meaningful clinical intervention can be made.

Clinical Outcomes

Read our latest paper to learn about how our sepsis AlgoDiagnostic improved clinical outcomes, across 75,147 patients from nine facilities over 18 months.
Burdick H, Pino E, Gabel-Comeau D, McCoy A, Gu C, Roberts J, Slote J, Saber N, Hoffman J, Das R, 
Effect of a Sepsis Prediction Algorithm on Patient Mortality, Length of Stay, and Readmission,  bioRxiv 457465. READ THE PAPER HERE

Our Footprint

We work with hospitals across eighteen states and our technology is used on hundreds of thousands of patients each year.
LEARN MORE
Our technology has been vetted through fifteen peer-reviewed publications.
 LEARN MORE
Over 50,000 clinicians (and climbing) use InSight in their daily sepsis care.

"We are seeing a positive impact for our patients through improved rates of survival."

HOYT J. BURDICK, MD
Chief Medical Officer
CABELL HUNTINGTON HOSPITAL

"InSight pushes results to clinicians so they can make more timely assessments."

LAWRENCE L. FALTZ, MD, MACP
Former Chief Medical Officer
PHELPS HOSPITAL | NORTHWELL HEALTH

Interested in learning more?

Contact Us